Awarded

Suministro de medicamentos exclusivos: suministro de medicamentos exclusivos Brolucizumab (BEOVU), Everolimus (VOTUBIA), Inclisiran (LEQVIO), Ceritinib (ZYKADIA) y Asciminib (SCEMBLIX) y Gozetotida 68GA (LOCAMETZ).

Track this recordFree account — get alerted when a contract here runs out.
Contract value
€840,866
Bids received
1
Published
8 Sept 2026
Awarded
27 May 2026
Contract start
27 May 2026
Contract end
28 May 2027estimated
Region
Madrid

More awards from this buyer